Internal Medicine · San Gabriel, CA
NPI
1417963661
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
415 W Valley Blvd, C
San Gabriel, CA, 91776
Phone (626) 943-9240
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
18,906 services
Medicare patients, 2024
1,110
Average age 78
Drug cost, 2024
$3.5M
50,607 prescriptions
Company payments, 2025
$507
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tai H Wu was code 99213 (office e&m - established), 5,573 times for 885 patients. In total Tai H Wu billed 18,906 services in 50 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-11-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 5,573 | 885 | $73.72 | $411K |
| 99442 Telephone Services | Office | 5,171 | 825 | $74.07 | $383K |
| 99232 Hospital E&M - Subsequent | Facility | 1,189 | 138 | $64.79 | $77K |
| 36415 Venipuncture Blood Collection | Office | 1,137 | 716 | $8.65 | $9,835 |
| 99308 SNF E&M | Facility | 1,071 | 141 | $62.66 | $67K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 708 | 708 | $140.35 | $99K |
| G0008 Administration of influenza virus vaccine | Office | 578 | 570 | $35.02 | $20K |
| 93000 Electrocardiogram | Office | 485 | 441 | $11.69 | $5,668 |
| 90662 Vaccine Product | Office | 370 | 370 | $81.82 | $30K |
| 85610 Clinical Chemistry | Office | 236 | 19 | $4.20 | $991 |
| 99233 Hospital E&M - Subsequent | Facility | 234 | 35 | $97.17 | $23K |
| 87426 Immunoassay | Office | 226 | 194 | $34.62 | $7,824 |
| 90653 Vaccine Product | Office | 175 | 174 | $81.82 | $14K |
| 99309 SNF E&M | Facility | 152 | 85 | $89.45 | $14K |
| 99214 Office E&M - Established | Office | 134 | 117 | $107.49 | $14K |
By year: 2022 $1.3M for 18,837 services; 2023 $1.3M for 19,192 services; 2024 $1.3M for 18,906 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,137 | 716 | $8.65 | $9,835 |
| 85610 Clinical Chemistry | 236 | 19 | $4.20 | $991 |
| 87426 Immunoassay | 226 | 194 | $34.62 | $7,824 |
| 81002 Clinical Chemistry | 59 | 49 | $3.41 | $201 |
| 83036 Blood Count | 54 | 47 | $9.52 | $514 |
Medicare prescription drug claims, 2024
In 2024, the drug Tai H Wu prescribed most often to Medicare patients was Atorvastatin Calcium, with 4,709 prescriptions and refills. In total Tai H Wu wrote 50,607 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 4,709 | 6,188 | 786 | $22K |
| Losartan Potassium Generic | 2,875 | 3,754 | 474 | $14K |
| Amlodipine Besylate Generic | 2,691 | 3,388 | 445 | $7,035 |
| Metformin Hcl Generic | 1,774 | 2,344 | 282 | $7,189 |
| Levocetirizine Dihydrochloride Generic | 1,547 | 1,708 | 615 | $7,951 |
| Montelukast Sodium Generic | 1,258 | 1,433 | 294 | $6,925 |
| Metoprolol Succinate Generic | 1,066 | 1,333 | 187 | $8,130 |
| Alendronate Sodium Generic | 956 | 1,272 | 202 | $4,812 |
| Azelastine Hcl Generic | 924 | 956 | 351 | $9,649 |
| Olmesartan Medoxomil Generic | 912 | 1,069 | 130 | $6,841 |
| Tamsulosin Hcl Generic | 890 | 1,099 | 170 | $7,645 |
| Diclofenac Sodium Generic | 855 | 863 | 439 | $17K |
| Omeprazole Generic | 801 | 864 | 311 | $3,134 |
| Gabapentin Generic | 706 | 753 | 152 | $4,633 |
| Januvia Sitagliptin Phosphate | 689 | 723 | 91 | $367K |
Brand drugs: 7,207 claims; generic drugs: 42,981 claims; opioid claims: 137.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tai H Wu $507 ($507 in general payments such as food, travel and fees) from 4 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $139.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.